iShares Core MSCI Emerging Markets ETF vs Nasdaq Inc — how do they compare? iShares Core MSCI Emerging Markets ETF trades at $81.4 (market cap $162.00B), while Nasdaq Inc trades at $93.65 (market cap $51.63B). The key difference: iShares Core MSCI Emerging Markets ETF is far larger — about 3.1× Nasdaq Inc's market cap, and Nasdaq Inc pays a 1.26% dividend while iShares Core MSCI Emerging Markets ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI Emerging Markets ETF for 57 Days and Nasdaq Inc for 126 Days on average.
| IEMG | NDAQ | |
|---|---|---|
Market Cap | $162.00B | $51.63B |
Volume | 13,446,151 | 2,668,175 |
Sector | Broad Market / Factor | Financials |
52-Week High | $86.00 | $100.98 |
52-Week Low | $64.22 | $76.85 |
Typical Hold Time | 57 Days | 126 Days |
Enterprise Value | — | $58.09B |
Dividend Yield | — | 1.26% |
Signals from Pluang's Aura AI — not financial advice
IEMG trades at $81.40, down 0.78% with bearish technical signals from moving averages while oscillators remain neutral. The emerging markets ETF has demonstrated strong performance with 35% returns over the past year according to recent analysis, though faces competition from lower-cost alternatives. Recent news highlights emerging markets attracting record capital flows as investors diversify beyond US mega-cap technology stocks.
The outlook remains cautiously optimistic given emerging markets' recent outperformance and dollar weakness, though higher expense ratios compared to competitors and concentration in technology sectors present risks. Technical indicators suggest near-term pressure with support at $79-80 levels, while fundamental strength in emerging market growth supports longer-term potential.
Nasdaq (NDAQ) trades at $92.37, up 0.48% with a bullish technical signal. The company shows strong fundamentals with Q2 2026 EPS beating expectations at $1.07 versus $0.984, and revenue growth from $7.4B in 2024 to $8.3B in 2025. Recent news highlights Nasdaq's AI-powered Calypso platform adoption by HSBC and Moderna joining the Nasdaq-100 Index, signaling business momentum. Valuation metrics include P/E of 26.93 and P/S of 6.07, with analyst consensus price target at $110.43.
NDAQ presents a favorable outlook with consistent earnings beats and strategic AI integration driving growth. Risks include market volatility sensitivity and debt levels, but strong institutional support and bullish analyst ratings suggest upside potential. The stock's current price offers a 19.6% discount to consensus target, making it attractive for growth-oriented investors seeking exposure to financial technology and market infrastructure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →